Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2020-02-15
2021-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acetazolamide and Exercise Performance at Altitude
NCT03525561
Effect of Acetazolamide on Maximal Exercise Performance in Lowlanders Older Than 40 Years at Altitude
NCT03536455
Acetazolamide to Prevent Impending Altitude-illness in Patients With COPD
NCT04913389
Does Statin Therapy Reduce Sympathoexcitation in Hypertension?
NCT00497016
Study of Atenolol Influence on Blood Pressure During Resistance Exercise
NCT01030016
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acetazolamide
Oral acetazolamide (250 mg/day) intake for 9 months
Acetazolamide
Daily acetazolamide pill intake
Atorvastatin
Oral atorvastatin (40 mg/day) intake for 9 months
Atorvastatin
Daily atorvastatin pill intake
Placebo
Oral placebo pill (daily) intake for 9 months
Placebo oral tablet
Daily placebo pill intake
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acetazolamide
Daily acetazolamide pill intake
Atorvastatin
Daily atorvastatin pill intake
Placebo oral tablet
Daily placebo pill intake
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 18 and 55 yrs
* Body mass index \<30kg/m²
* Born at \>3500 m, living for \>3 years at the local high altitude
* No diagnosis of cardiorespiratory, metabolic or neurological diseases
* No drug intake
* No smoker
* Chronic mountain sickness score ≥6
Exclusion Criteria
* Systolic \> 130 mmHg and/or diastolic \> 85 mmHg blood pressure
* Drug intake
* Smoker
* Chronic mountain sickness score \<6
18 Years
55 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre d'Expertise sur l'Altitude EXALT
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Samuel Verges, PhD
Role: PRINCIPAL_INVESTIGATOR
EXAL
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Association EXALT, UM Sport Pathologies, Hôpital Sud, Avenue Kimberley
Échirolles, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Expedition5300
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.